News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
EU Raids Drug Companies Including Pfizer Inc., GlaxoSmithKline and AstraZeneca PLC in Broad Inquiry
January 16, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
BRUSSELS/LONDON (Reuters) - The European Commission raided some of the world's largest drugmakers on Wednesday, launching a broad investigation into whether they made illegal deals or abused patents to limit competition and harm consumers.
Twitter
LinkedIn
Facebook
Email
Print
Regulatory
Europe
AstraZeneca
Johnson & Johnson Family of Companies
Merck & Co.
Pfizer
Sanofi
GSK
MORE ON THIS TOPIC
FDA
FDA reverses course on Atara, Pierre Fabre’s twice-rejected cell therapy after Prasad’s exit
May 7, 2026
·
3 min read
·
Heather McKenzie
FDA
Sanofi requests removal of Tzield from CNPV program after Høeg gets involved
May 7, 2026
·
4 min read
·
Heather McKenzie
Policy
Makary defends Replimune melanoma rejection again as FDA tensions build
May 6, 2026
·
3 min read
·
Tristan Manalac
Podcast
Pfizer, Lilly, more report Q1, FDA names acting CBER director and an ALS awakening
May 6, 2026
·
1 min read
·
Heather McKenzie